EP Patent

EP3600314A1 — Niraparib compositions

Assigned to Tesaro Inc · Expires 2020-02-05 · 6y expired

What this patent protects

The present invention relates to compositions comprising the compound niraparib, in particular certain solid forms of niraparib.

USPTO Abstract

The present invention relates to compositions comprising the compound niraparib, in particular certain solid forms of niraparib.

Drugs covered by this patent

Patent Metadata

Patent number: EP3600314A1
Jurisdiction: EP
Classification: —
Expires: 2020-02-05
Drug substance claim: No
Drug product claim: No
Assignee: Tesaro Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.